Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine)

Keyphrases

• First Dose 100%
• SARS-CoV-2 Vaccine 100%
• Polyethylene Glycol Antibodies 100%
• Comirnaty Vaccine 100%
• MRNA-LNP 100%
• Comirnaty 100%
• Polyethylene Glycol 66%
• Adverse Reactions 66%
• Israel 33%
• Lipids 33%
• Adverse Effects 33%
• Vaccination 33%
• Concentration-dependent 33%
• Humanized 33%
• Israeli Population 33%
• Low Affinity 33%
• Large Amount of Data 33%
• High Titer 33%
• PEGylated Nanoliposome 33%
• PEG2000 33%
• PEGylated Drug 33%
• Vaccination Campaign 33%
• Vaccine Administration 33%
• Early Vaccination 33%
• PEGylated Liposomes 33%
• SARS-CoV-2 Virus 33%
• PEG-lipid 33%
• PEGylated Proteins 33%
• IgG Concentration 33%
• Pfizer-BioNTech Vaccine 33%
• Massive Vaccination 33%
• Vaccine against COVID-19 33%
• Reactogenicity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Macrogol 100%
• COVID-19 Vaccine 100%
• Messenger RNA 100%
• Adverse Event 60%
• Liposome 40%
• Immunoglobulin M 40%
• Immunoglobulin E 20%
• Mole (Insectivora) 20%
• SARS Coronavirus 20%

Immunology and Microbiology

• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Immunology 100%
• Immunoglobulin M 66%
• Immunoglobulin E 33%
• COVID-19 33%
• Titer 33%
• Mole (Insectivora) 33%